ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

ClinicalTrials.gov ID: NCT04614467

Public ClinicalTrials.gov record NCT04614467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease

Study identification

NCT ID
NCT04614467
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Lisata Therapeutics, Inc.
Industry
Enrollment
34 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2020
Primary completion
Sep 27, 2022
Completion
Sep 27, 2022
Last update posted
May 3, 2026

2020 – 2022

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048
University of Florida - College of Medicine/ div of Cardiovascular Medicine Gainesville Florida 32606
Memorial Regional Hospital Hollywood Florida 33021
Emory University Hospital Atlanta Georgia 30322
Minneapolis Heart Institute at Abbott Northwestern Hospital Minneapolis Minnesota 55407
Mayo Clinic in Rochester Rochester Minnesota 55905
The Christ Hospital Cincinnati Ohio 45219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04614467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04614467 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →